Networking

Networks and linkages
The three nodes of the CBTBR are involved in wide collaborative networks that involve TB researchers and research institutions in a large number of countries. Maintaining existing  collaborative  networks  and developing  new  linkages  is of  critical  importance  to  the CBTBR. For this reason, members continued to devote significant time and effort to networking.

International Collaborators - click to open or close information

CoE Primary Contact

CoE Node

Collaborating Partner

Institution

Research Area

Country in which collaborating institution is based

Prof. Sampson

SU

Dr. Mardassi

Institut Pasteur de Tunis

Characterisation of LAM evolutionary history (2007-present).; Determining the role of PPE_MPTR proteins in TB pathogenesis: functional and computational analysis

Tunisia

Prof. Sampson

SU

Dr. Bitter

Vrije Universiteit

The trafficking of the M. tuberculosis PE and PPE proteins (2006 – present). ESX secretion in Beijing genotype strains

Netherlands

Prof. Warren

SU

Dr. Supply,

Institut Pasteur Lille

Evaluation of hypervariable VNTR regions for the discrimination of Beijing genotype strains

France

Prof. Warren

SU

Dr. Horseburgh

Boston University

Deep sequencing for fluoroquinolone resistance

USA

Prof. Warren,
Dr.  Streicher

SU

Prof. Gagneux

Swiss TPH, Basel

Collaboration on genome sequencing of clinical strains of M. tuberculosis

Switzerland

Prof. Warren,
Dr. Streicher, Dr. de Vos

SU

Prof. Wangh and
Prof. Kreiswirth

Brandis University, HPRI,

Evaluation of LATE PCR for the detection of resistance to first and second-line anti-TB drugs.

USA

Prof. Warren

SU

Prof. Kreiswirth

HPRI

Whole Genome Sequencing of NTMs

USA

Prof. van Helden

 

Prof. Walzl

SU

 

SU

Dr. Barry III,
Dr. H Boshoff

Tuberculosis Research Section, Laboratory of Host Defenses, National Institute of Allergy & Infectious Diseases, NIH, MD

Ongoing collaboration on the HIT-TB project

 

TB treatment response project

USA

Prof. Ronacher,
Dr. Kleynhans

SU

Prof. Restrepo

University of Texas

ALERT: Altered endocrine axis during type 2 diabetes and risk for tuberculosis

USA

Prof. Ronacher,
Dr. Kleynhans

SU

Prof. Schlesinger

Ohio State University

ALERT: Altered endocrine axis during type 2 diabetes and risk for tuberculosis

USA

Prof. Walzl,
Dr. du Plessis,
Dr. Loxton, 
Dr. Beltran and
Dr. Fang

SU

Prof. Belisle

Colorado State University

Biosignatures/ICIDR:

USA

Prof. Walzl,
Dr. Loxton

SU

Prof. Kaufmann

Max Planck IIB

TBVac

Germany

Prof. Walzl

SU

Prof. Dockrell

LSHTM

TBVac

United Kingdom

Prof. Ronacher,
Prof. Walzl

SU

Prof. Dockrell

LSHTM

TANDEM – Concurrent Tuberculosis and Diabetes

United Kingdom

Prof. Walzl, Dr. Loxton and Dr. Chengou

SU

Prof. Ottenhoff

Leiden University

Ongoing collaboration of biomarkers for TB diagnostics

Netherlands

Prof. Warren

SU

Prof. Sterling

Vanderbilt University Tuberculosis Center

Fluoroquinolone resistance

USA

Prof. Warren,
Dr. Streicher

SU

Prof. Murray

Florida University Harvard / Broad institute

Various project including the evolution of XDR-TB strains; other mechanisms of drug resistance (in addition to genomic mutations); mechanisms of resistance to 2nd line drugs; strain fitness; certain strain families may have both increased fitness and increased potential for acquiring drug resistance.

USA

Prof. Warren,
Dr. Streicher

SU

Dr. Jacobson

Harvard University

1)   GIS of drug resistant TB in the Western Cape

USA

Prof. Warren,
Dr. Streicher

SU

Dr. Jacobson

Harvard University

2)   Health systems reserach

USA

Dr. Smith,
Prof. Warren

SU

Prof. McNerey

LSTHM

Whole genome sequencing of drug resistant M. tuberculosis strains

United Kingdom

Prof. Sampson,
Prof. Warren

SU

Prof. Anab Pain

KAUST

Whole Genome Sequencing of Mycobacterial Species

Saudi Arabia

Prof. Hoal van Helden

SU

Prof. Erwin Schurr

McGill University

Genetic epidemiology.

Canada

Prof. Hoal van Helden

SU

Prof. Abel &
Prof. Alcais

INSERM / Université

Analysis of genetic epidemiology.

France

Prof. Hoal van Helden

SU

Prof. Casanova

Rockefeller University

Human genetics of TB resistance in HIV-infected persons

USA

Prof. Hoal van Helden

SU

Prof. Fitzgerald

Weill Cornell

Human genetics of TB resistance in HIV-infected persons

USA

Prof. Hoal van Helden

SU

Prof. Geissmann

MSKCC (Sloan Kettering)

Human genetics of TB resistance in HIV-infected persons

USA

Prof. Hoal van Helden

SU

Prof. Glickman

MSKCC (Sloan Kettering)

Human genetics of TB resistance in HIV-infected persons

USA

Prof. Hoal van Helden

SU

Prof. Barreiro

University of Montreal

Human genetics of TB resistance in HIV-infected persons

Canada

Prof. Hoal van Helden

SU

Dr. Price

Harvard School of Public Health

Computational assistance with analysis of admixture mapping.

USA

Prof. Hoal van Helden

SU

Dr. Henn

Stony Brook University

Population Ancestry genetic determinations.

USA

Prof. Hoal van Helden

SU

Dr. Capelli

Oxford University

Population Ancestry genetic determinations.

United Kingdom

Prof. Hoal van Helden

SU

Prof. Schreiber,
Dr. Nebel,
Dr. Franke

Christian-Albrechts University

Investigation of candidate genes in TB.

Germany

Prof. Hoal van Helden

SU

Dr. Gignoux

Stanford University

Population Ancestry genetic determinations.

USA

Prof. Warren,
Dr. Streicher,
Prof. Theron

SU

Dr.  Metcalfe

University of South Florida

Deep sequencing to identify heteroresistance

USA

Prof. Warren,
Dr. Streicher,
Prof. Theron

SU

Prof. Engelthaler

Translational Genomics Research Instituite (Tgen)

Deep sequencing to identify heteroresistance

TSA

Prof. Warren,
Prof. Tromp

SU

Prof. van Rie,

UNC - Gillings School of Global Public Health

Evaluation of the Xpert MTB/RIF test.

USA

Prof. Sampson

SU

Prof. Wigneshweraraj

Imperial College London

The identification of novel inhibitors of RNA polymerase in Mycobacterium tuberculosis

United Kingdom

Prof. Sampson

SU

Dr. Massey

University of Bath

GWAS of M. tuberculosis strains

United Kingdom

Prof. Warren,
Dr. Streicher

SU

Prof. Rastogi

Pasteur Institute

Spoligotyping TB in Africa

France

Dr.  Baker,
Prof. Wiid

SU

Dr. Carolis

Centre for Genomic Regulation

Screening for Ergothioneine specific anti-TB drugs

Spain

Dr. Kinnear,
Dr. Möller

SU

Prof. Crow

University of Manchester

Identification of gene mutations that cause Primary Immunodeficiency Disorders.

United Kingdom

Dr. Kinnear,
Dr. Möller

SU

Prof. Lung

University of Hong Kong

Identification of gene mutations that cause Primary Immunodeficiency Disorders.

China

Dr. Möller,
Prof. Hoal van Helden

SU

Prof. van Furth                 

VU University Medical Center

Tuberculosis Meningitis

Netherlands

Dr. Möller,
Prof. Hoal van Helden

SU

Dr. van der Kuip

VU University Medical Center

Tuberculosis Meningitis

Netherlands

Prof. Walzl, Dr. du Plessis, Dr. Loxton

SU

Dr. Reed

IDRI - Infectious Diseases Research Institute

ID-93 Vaccine

USA

Prof. Walzl, Dr. Loxton,
Dr. Gutschmidt

SU

Dr. Grode

VPM - Vakzine Projekt Management

VPM1002 phase II vaccine trial

Germany

Dr. du Plessis, Prof. Walzl

SU

Dr. Dorhoi

MPIIB - Max Planck Institute for Infection Biology

Host-directed Therapy and MDSCS

Germany

Dr. du Plessis,
Prof. Walzl,
Dr. Kleynhans

SU

Dr. Lewinsohn

Ohio State University

MAIT cells

USA

Prof. Walzl, Dr. Loxton

SU

Dr. Macete

CISM - Centro de Investigação em Saúde de Manhiça

TESA

Mozambique

Dr. Loxton

SU

Dr. Chiodi

Karolinska Institute

Bcell phenotypes in TB and HIV

Sweden

Prof. Theron

SU

Prof. Segal

New York University

TB Microbiome

USA

Prof. Theron

SU

Dr. van denDriesche

Radboud University

TB Aerobiology

Netherlands

Prof. Theron

SU

Dr. McFall

Northwestern University

TB Diagnostics

USA

Prof. Theron

SU

Dr. Steingart

Cochrane Collaboration

Systematic reviews and meta-analyses

USA

Prof. Theron

SU

Prof. Nardell

Harvard University

TB infection control and transmission

USA

Prof. Mizrahi & Prof. Warner

UCT

Dr. Barry III and Dr. Boshoff

NIAID, NIH

TB drug discovery (HIT-TB consortium)

USA

Prof. Mizrahi

UCT

Prof. Cole

École Polytechnique Fédérale de Lausanne

TB drug discovery (MM4TB Consortium)

Switzerland

Prof. Mizrahi

UCT

Prof. Rizzi

University of Piemonte Orientale

TB drug discovery (MM4TB consortium)

Italy

Prof. Mizrahi UCT Prof. Mikusova Comenius University Bratislava TB drug discovery
(MM4TB consortium)
Slovak Republic
Prof. Mizrahi UCT Prof. Blundell & Dr. Ascher University of Cambridge TB drug discovery (HIT-TB and MM4TB Consortia) UK
Prof. Mizrahi UCT Dr. Pato & Gyorgy Keri Vichem Chimie, Budapest TB drug discovery (MM4TB consortium) Hungary
Prof. Mizrahi UCT Drs. Lagrange and Mondesert Sanofi-Aventis R&D TB drug discovery (MM4TB consortium) France
Prof. Mizrahi & Prof. Warner UCT Prof. McKinney &
Dr. Dhar
École Polytechnique Fédérale de Lausanne TB drug discovery (MM4TB Consortium); mutational mechanisms in mycobacteria Switzerland
Prof. Mizrahi & Prof. Warner UCT Prof. Müller Helmholtz Institute for Pharmaceutical Sciences TB drug discovery focused on natural products Germany
Prof. Mizrahi UCT Profs. Hung, Rubin & others Broad Institute of MIT & Harvard,  Harvard Medical School & Harvard School of Public Health Factors mitigating TB drug efficacy (TB Gift consortium) USA
Prof. Warner & Prof. Mizrahi UCT Dr. Woodgate NICHD, NIH The association between persistence and resistance in Mtb USA
Prof. Warner UCT Prof. Russell Cornell University Drug permeation in Mtb USA
Prof. Mizrahi, Dr. Evans & Prof. Warner UCT Prof. Rhee Weill Cornell Medical College Application of metabolomics in TB drug discovery USA
Prof. Mizrahi & Dr. Warner UCT Profs. Schnappinger & Ehrt Weill Cornell Medical College In vivo phenotyping of Mtb mutants USA
Prof. Warner & Prof. Mizrahi UCT Drs. Olsen & Young Merck Research Laboratories TB drug discovery (TB Drug Accelerator) USA
Prof. Mizrahi & Prof. Warner UCT Prof. Wyatt, Dr. Green & Dr. Ray University of Dundee TB Drug discovery (HIT-TB consortium and TBDA) UK
Prof. Warner & Prof. Mizrahi UCT Dr. Huwe Bayer AG TB drug discovery (TBDA) Germany
Prof. Warner UCT Dr. Andrews Stanford University TB transmission USA
Prof. Warner UCT Prof. Venclovas Institute of Biotechnology, Vilnius Homology modelling of DNA polymerases Lithuania
Prof. Warner UCT Prof. Lamers University of Cambridge Enzymology of NA polymerases of mycobacterial origin UK
Prof. Warner UCT Dr. Rock Harvard School of Public Health Replication fidelity in mycobacteria USA
Prof. Mizrahi UCT Prof. Gordon University of Oxford Macrophage models of TB infection UK
Prof. Warner UCT Dr. Mathema Columbia University Mtb genomics USA
Prof. Mizrahi & Dr. Evans UCT Prof. Dowd George Washington University Targeting the CoA pathway for TB drug discovery USA
Prof. Kana Wits Neeraj Dhar École polytechnique fédérale de Lausanne Single cell analysis of peptidoglycan remodelling and resuscitation in mycobacteria: Implications for TB disease. Switzerland
Prof. Kana Wits Carolyn Bertozzi Stanford University Analysis of fluorogenic trehalose derivatives as diagnostic reagents for tuberculosis USA
Prof. Kana Wits Sung Joon Kim Baylor University Compositional Analysis of peptidoglycan in mycobacteria USA
Dr. Peters Wits Bryan Sheppard Vanderbilt University Characterization of differentially culturable tubercle bacteria in tuberculosis disease USA
National Collaborators

CoE Primary Contact

CoE Node

Collaborating Partner

Institution

Research Area

Prof. van Helden

SU

Prof. Chibale and other members of H3D

H3D Drug Discovery & Development Centre, UCT

Ongoing collaboration on SATRII, HI-TB and H3-D TB drug discovery projects

Prof. Warren

SU

Prof. Wilkinson

CIDRI, IDM

Collaboration on sequence analysis of clinical strains of M. tuberculosis

Prof. van Hoal

SU

Prof. Wilkinson

CIDRI, IDM

Human genetics of TB resistance in HIV-infected persons

Prof. Warren,
Dr. Streicher

SU

Dr. Cox

UCT

Evolution of drug resistance in HIV positive and negative individuals

Dr. Smith,
Prof. Warren,
Dr. Streicher

SU

Prof. Dheda

UCT

Molecular epidemiology of XDR-TB

Dr. Smith

SU

Whole genome sequencing of XDR-TB

Prof. Walzl

SU

Collaboration in diagnostic/biomarker project

Prof. Warren,
Dr. Werely

SU

Prof. Christoffels

SANBI, UWC

Bioinformatic analysis of whole genome sequence data.Wet-lab testing of computationally identified inhibitors

Prof. Warren

SU

Dr. Ismail

NHLS

Drug resistant TB in South Africa

Prof. Warren

SU

Dr. Theron

Eben donges hospital, Worcester

New project on DOTS program on farms.

Prof. Warren

SU

Prof. Scott,
Prof. Stevens

University of the Witwatersrand

Ongoing collaboration on the rollout of the GeneXpert diagnostic test and establishment of an external quality assurance system.

Prof. Warren

SU

Prof. Blackburn

IDM, UCT

Collaboration on lipidomic and proteomic analyses of M. tuberculosis strains

Prof. Warren,
Prof. Sampson

SU

Prof. Mulder

CBIO, IDM, UCT

Collaboration on bioinformatic analysis of mycobacterial genomes and transcriptomes

Prof. Warren

SU

Dr. Chihota

Aurum Health

M. tuberculosis strain population structure in Africa.

Dr. Baker, Prof. Wiid

SU

Prof. Loots

North West University, Potchefstroom

Mouse Macrophagemetabolome.

Prof. Warren

SU

Prof. Wright

NHLS Port Elizabeth

The diagnostic utility of FNAB

Dr. Baker, Prof. Wiid

SU

Dr. Haynes

North West University, Potchefstroom

Study novel artemisinins for antimycobacterial activity

Dr. Baker, Prof. Wiid

SU

Dr. Kruger

Chemistry, UKZN, Durban

Screen antituberculosis lead compounds

Prof. Warren,
Dr. Streicher,
Dr. De Vos

SU

Mrs. Dolby

NHLS , Green point

Collaborator provides routine samples.

 

SU

Dr. Hesseling

SU

New collaboration to investigate genotype-immunological phenotype correlations in children.

Prof. Warren,
Prof. Walzl

SU

Collaboration of developing a stool TB diagnostic

Prof. Ronacher,
Dr. Kleynhans

SU

Prof. Jacobs

UCT

New collaboration to assess the impact of steroid hormones on protective immunity to M. tb in a mouse animal model.

Prof. Warren

SU

Dr. Walters

Department of Pediatrics and Child Health, Stellenbosch University

Improved detection of M. Tb by Xpert MTB/RIF in gastric aspirates and stool samples collected from children with suspected pulmonary TB.

Dr. Kinnear,
Dr. Möller

SU

Dr. Esser

NHLS Immunology Unit, Tygerberg Hospital

Identification of gene mutations that cause Primary Immunodeficiency Disorders.

Dr. Möller

SU

Prof. Moosa

Dept. Medicine, SU

Investigating chromosome 22 genetic polymorphisms as risk factors for HIVAN in South African adults: a pilot case-control study

Dr. Möller

SU

Prof. van Toorn

Dept of Medicine, SU

Investigating susceptibility to tuberculous meningitis

Dr. Möller

SU

Dr. Solomons

Prof. Walzl,
Dr. Loxton,
Dr.Chegou

SU

Kogie Naido

CAPRISA

Systems immunology project

Prof. Walzl,
Dr. Loxton,
Dr.Chegou

SU

Gavin Churchyard

Aurum Institute

Systems immunology project

Prof. Walzl,
Dr.Loxton

SU

Prof. Hatherill

SA Tuberculosis Vaccine Initiative (SATVI), UCT

CORTIS: The Correlate of Risk Targeted Intervention Study

SU

Prof. Scriba

Prof. Walzl

SU

Prof. Scriba

SATVI, IDM, UCT

Ongoing collaboration on TB transmission

Prof. Walzl,
Dr. Malherbe,
Dr. Loxton

SU

Prof. Cotton

FamCru

CORTIS

Prof. Miller,
Dr. Parsons

SU

Prof. Michel

Dept of Tropical Diseases, University of Pretoria

Ongoing collaboration on TB diagnostics in buffalo and elephants

Prof. Miller,
Dr. Parsons

SU

Dr. Cooper

Ezemvelo KwaZulu Natal Wildlife, KZN

Ongoing collaboration on TB test development in buffalo

Prof. Miller,
Dr. Parsons

SU

Dr. Buss

South African National Parks - Kruger NP

Investigation of TB in rhinoceros, elephants, warthogs, lions, antelope

Prof. Miller,
Dr. Parsons

SU

Dr. deKlerk-Loris

Office of the State Veterinarian, Kruger NP

Investigation of TB in rhinoceros, elephants, warthogs, lions, antelope

Prof. Miller,
Dr. Parsons

SU

Dr. van Schalkwyk

Office of the State Veterinarian, Kruger NP

Investion of TB in rhinoceros, elephants, warthogs, lions, antelope

Prof. Miller,
Dr. Parsons

SU

Dr. Foggin

Victoria Falls Wildlife Trust, Zimbabwe

Ongoing collaboration on TB in elephants and banded mongoose

Prof. Miller,
Dr. Parsons

SU

Dr. Olea-Popelka

Colorado State University, Faculty of Vet. Med., USA

Long-term collaboration on TB projects in wildlife and zoonotic TB

Prof. Miller,
Dr. Parsons

SU

Dr. Patterson

Royal Veterinary College, UK

Investigation of TB detection in meerkats

Prof. Miller,
Dr. Parsons

SU

Dr. Ro, Dr. Bakere Austerman

National Veterinary Services Laboratory, USA

Collaborating on determining WGS on animal TB isolates

Prof. Miller,
Dr. Parsons

SU

Dr. Lane

National Zoological Gardens of Pretoria

Collaboration on pathological changes associated with TB infection in wildlife species

Prof. Miller,
Dr. Parsons

SU

Dr. Lyashchenko

Chembio Diagnostic SystDr Lizma Streicher, Inc, USA

Investigation of rapid serological tests for wildlife TB

Prof. Sampson

SU

Prof. Malan

School of Pharmacy, UWC

Investigating the Potential Anti-mycobacterial Effect of Novel Polycyclic Compounds on Mycobacterium tuberculosis

Prof. Sampson

SU

Dr. Dube

School of Pharmacy, UWC

Assessing the anti-mycobacterial and immuno-modulatory effect of nanoparticles

Prof. Sampson

SU

Prof. Wolfaardt

Stellenbosch University Water Institute

Mycobacterial persisters and biofilms

Dr. Baker, Prof. Wiid

SU

Prof. Chibale

Chemistry, UCT

Ongoing collaboration on TB drug discovery projects

Dr. Baker, Prof. Wiid

SU

Prof. Afolayan

Faculty Science and Agriculture, Fort Hare University

Identify anti-TB compounds from traditional herbal extracts

Dr. Baker, Prof. Wiid

SU

Prof. Kruger

Dept. of Chemistry, UKZN

Development of anti-TB compounds

Dr. Kinnear,
Dr. Möller

SU

Dr. Loos

SU. Department of Physiological Scences

Study investigating the mechanisms of autophagy induction by different MTB strains

Prof. Warren,
Dr. Streicher

SU

Tim Rodwell, FIND

FIND

Whole Genome Sequencing and phenotypic DST

Prof. Warren

SU

Helen Jenkins

BU

Spacial Medicine

Prof. Warren,
Prof. Theron

SU

Prof. Perold

SU

Biosensors

Prof. Warren

SU

Marco Schito

CPTR

Whole Genome Sequencing

Prof. Warren,
Dr. Streicher

SU

Cindy Heyens

NHLS - PE

Isoniazid discrepant DST

Prof. Warren,
Dr. Streicher

SU

Yuri van der Heijden

Vanderbilt University Tuberculosis Center, Nashville, USA

Evolution of FQ resistance

Prof. Warren

SU

Prof. Clarke

LSTHM

Pacbio WGS

Dr. Kinnear,
Dr. Möller

SU

Dr. van Vuuren

SU Division of Physiological Sciences

Investigting the regulation of phospotases in cardiomyocytes during hypoxia

Dr. Kinnear

SU

Dr. Peter

UCT Department of Medicine

Using whole exome sequencing to identify novel PID-causing genes as a measn to identiy novel TB susceptibility genes.

Dr. Möller

SU

Dr. Zaharie

Anatomical Pathology, Tygerberg Hospital

Tuberculosis Meningitis

Prof. van Hoal,
Dr. Möller

SU

Dr. Chimusa

CBIO, IDM, UCT

Host genetic susceptibility to TB

Dr. du Plessis,
Prof.Walzl

SU

Dr. Horsnell

UCT

Helminth-TB humoral responses

 

 

 

 

 

Prof. Warner & Prof. Mizrahi

UCT

Prof. Wood

UCT

TB transmission

Prof. Warner & Prof. Mizrahi

UCT

Profs. Scriba, Mulder & Blackburn

UCT

TB transmission

Prof. Warner

UCT

Prof. Chibale

UCT

TB drug discovery (co-supervision of students)

Prof. Warner

UCT

Dr. Wiesner

UCT

TB drug permeation (co-supervision of students)

Prof. Warner

UCT

Prof. Steyn

AHRI, UKZN

Energy metabolism in Mtb

Prof. Warner & Prof. Mizrahi

UCT

Prof. Wilkinson

UCT

Genome evolution in Mtb

Prof. Warner

UCT

Dr. Middlekoop

UCT

TB transmission

Prof. Warner

UCT

Prof. Egan

UCT

Small molecule permeation in mycobacteria

Prof. Mizrahi & Dr. Evans

UCT

Prof. Strauss

Stellenbosch University

Targeting the CoA pathway for TB drug discovery

Prof. Warner

UCT

Dr. Mhlanga

CSIR-UCT Biomedical Translational Research Initiative

Advanced imaging applied to mycobacteria

 

Dr. Gordhan

Wits

Debra Meyer

University of Pretoria and University of Johannesburg

Identification of small compounds with bioactivity again Mycobacterium tuberculosis

Dr. Chengalroyen

Wits

Stoyan Stoychev

Council for Scientific and Industrial Research

Peptidoglycan recycling in mycobacteria

Dr. Chengalroyen

Wits

Dr. Streicher

University of Stellenbosch

Genotyping of M. tuberculosis isolates

Prof. Kana

Wits

Xavier Padanilam

Sizwe Hospital

Genotypic and phenotypic heteroresistance of extensively drug resistant isolates

Dr. Chengalroyen

Wits

Nazir Ismail

National Institute for Communicable Diseases

Genotyping of M. tuberculosis isolates

Prof. Kana

Wits

Nesri Padayatchi/Kogie Naidoo

Centre for AIDS Prevention Research in South Africa

Various clinical projects (eg. Praxis)



Networking

Enquiries: See contact us

© CBTBR 2006 | Last updated: 1 September, 2017